Ici, vous êtes en bonne compagnie.

Consultations et rendez-vous

Clinique CHC Heusy - Hémato-oncologie - Tél. 087 21 37 02

Prendre rendez-vous
Lundi Mardi Mercredi Jeudi Vendredi Samedi
AM
PM

AM PM
Lundi
Mardi
Mercredi
Jeudi
Vendredi
Samedi

Clinique CHC MontLégia - Hémato-oncologie - Tél. 04 355 50 35

Prendre rendez-vous
Lundi Mardi Mercredi Jeudi Vendredi Samedi
AM
PM

AM PM
Lundi
Mardi
Mercredi
Jeudi
Vendredi
Samedi

Clinique CHC Waremme - Hémato-oncologie - Tél. 019 33 94 41

Prendre rendez-vous
Lundi Mardi Mercredi Jeudi Vendredi Samedi
AM
PM

AM PM
Lundi
Mardi
Mercredi
Jeudi
Vendredi
Samedi

Cabinets médicaux Haie des Chênes - Hémato-oncologie - Tél. 04 384 74 00

Lundi Mardi Mercredi Jeudi Vendredi Samedi
AM
PM

1er et 3e mercredi du mois

AM PM
Lundi
Mardi
Mercredi
Jeudi
Vendredi
Samedi

1er et 3e mercredi du mois

En savoir plus

Spécialisations

  • Médecine interne - Oncologie (ULiège, 1992)

Centres d'intérêt

  • Hématologie clinique

Publications

  • Focan C, Kreutz F, Longrée L, Graas MP, Moeneclaey N, Demolin G, Focan-Henrard D. Interest of chronotherapy in multidisciplinary management of oesophageal and gastric cancers. Pathol Biol (Paris). 2007 Apr-May; 55(3-4): 181-5. 

  • Focan C, Bury J, Matus G, Graas MP, Kreutz F, Longree L, Moeneclaey N, David A, Focan-Henrard D. Adjuvant chemotherapy for Dukes B2 and C colon cancer combining 5-fluorouracil and folinic acid with or without carboplatin. Feasibility and comparison between standard and chronomodulated deliveries.Pathol Biol (Paris). 2005 Jun; 53(5): 281-4. 

  • Focan C, Kreutz F, Graas MP, Longrée L, Moeneclaey N, David A, Focan-Henrard D. Feasibility survey (Phase I-II) of a four drugs combination (5-fluorouracil, folinic acid, carboplatin and irinotecan) delivered using a chronomodulated infusion in the treatment of advanced colorectal cancer. Pathol Biol (Paris). 2005 Jun;53(5): 277-80.

  • Focan C, Kreutz F, Longrée L, Graas MP, Focan-Henrard D, Moeneclaey N, David A, Biquet JF, Materne R, Weerts J, Delforge M. Chronotherapy combining 5-fluorouracil, folinic acid and carboplatin as first line treatment in metastatic colorectal cancer. A phase 2 study. Pathol Biol (Paris). 2005 Jun; 53(5): 273-6.

  • Herens C, Tassin F, Lemaire V, Beguin Y, Collard E, Lampertz S, Croisiau C, Lecomte M, De Prijk B, Longrée L, Koulischer L. Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. Br J Haematol. 2000 Jul; 110(1): 214-6.

  • Fraipont V, Sautois B, Baudoux E, Pereira M, Fassotte MF, Hermanne JP, Jérusalem G, Longrée L, Schaaf-Lafontaine N, Fillet G, Beguin Y. Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF.Transfusion. 2000 Mar; 40(3): 339-47.

  • Graas MP, Evrard P, Creemers E, Longrée L, Limet R, Focan C. Clinical case of the month. Metastatic endocarditis: clinical observation and review of the literature. Rev Med Liege. 1998 Oct; 53(10): 588-91. 

  • Mohnen L, Heedfeld T, Focan-Henrard D, Kreutz F, Longree L, Focan C. Ambulatory chrono-chemotherapy by portable pumps: feasibility and compliance. Nursing aspects. In Vivo. 1995 Nov-Dec;9(6): 565-71.

  • Longrée L, Focan C, Bury J, Beauduin M, Brohee D, Duvivier A, Lecomte M, Markiewicz S, Vindevoghel A, Weerts J. Levamisole adds granulocyte toxicity to 5FU-based chemotherapies in adjuvant treatment of Dukes B-C colorectal cancer. A preliminary report. Anticancer Res. 1995 Jul-Aug; 15(4): 1561-4.

  • Longree L, Pautier P, Guilhot F, Brice P. Pregnancy occurring during complete cytogenetic response after interferon therapy in chronic myeloid leukaemia. Nouv Rev Fr Hematol. 1995; 37(4): 249-50.

Voir plus